Products

- "We manufacture and supply products as per client's specific requirements"

The following impurities are available with SUMA Laboratories Pvt Limited. Click here to Download our impurities in pdf format...UPDATED

Product list 1 - 50:

S.No Compound Name CAS Remarks
1 1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol
C24H26N2O4
M.Wt.: 406.47 		72956-09-3 Carvedilol
2 4-(oxiran-2-ylmethoxy)-9H-carbazole
C15H13NO2
M.Wt.: 239.27 		51997-51-4 Carvedilol  related
compound
Carvedilol USP-D
3 1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethyl-propan-2-ylamino]propan-2-ol
C27H32 N2O4
M.Wt.: 448.5 		1246819-01-1 Carvedilol  related
compound
4 2-(2-methoxyphenoxy)ethanamine
C9Hsub>13sub>NO2sub>
M.Wt.: 167.21 		1836-62-0 Carvedilol USP-A
5 1-[4-[2-hydroxy-3-[2-(2-methoxyphenoxy)ethylamino]propoxy]carbazol-9-yl]-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol
C36H43N3O7
M.Wt: : 629.74 		1198090-73-1 Carvedilol USP-A
Carvedilol EP Impurity A
6 1-(9H-carbazol-4-yloxy)-3-[[3-(9H-carbazol-4-yloxy)-2-hydroxypropyl]-[2-(2-methoxyphenoxy)ethyl]amino]propan-2-ol
C39H39N3O6
M.Wt: 645.74 		918903-20-5 Carvedilol USP-B
Carvedilol EP Impurity B
7 1-[benzyl-[2-(2-methoxyphenoxy)ethyl]amino]-3-(9H-carbazol-4-yloxy)propan-2-ol
C31H32N2O4
M.Wt. 496.60 		72955-94-3 Carvedilol EP Impurity C
Carvedilol Impurity C
Carvedilol USP-C
8 1-[9-[3-(9H-carbazol-4-yloxy)-2-hydroxypropyl]carbazol-4-yl]oxy-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol
C39H39N3O6
M.Wt: 645.74 		1391052-16-6 Carvedilol EP Impurity D
9 1-(9H-carbazol-4-yloxy)-3-[2-[2-[2-[[3-(9H-carbazol-4-yloxy)-2-hydroxypropyl]amino]ethoxy]phenoxy]ethylamino]propan-2-ol
C40H42N4O6
M.Wt.: 674.78 		1346602-98-9 Carvedilol related compound
10 2-[2-(cyanomethoxy)phenoxy]acetonitrile 27165-64-6 Carvedilol impurity
11 2-[2-(cyanomethoxy)phenoxy]acetonitrile 27165-64-6 Carvedilol impurity
12 2-(5-methoxy-1H-indol-3-yl)ethanamine hydrochloride
C11H15ClN2O
M.Wt.: 226.70 		66-83-1 Melatonin Related compound
13 N-[3-(2-formamido-5-methoxyphenyl)-3-oxopropyl]acetamide
C13H16N2O4
M.Wt.: 264.28 		52450-38-1 Melatonin degradant
14 4-ethyl-3-methyl-N-[2-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide
C24H34N4O5S
M.Wt.: 490.62 		684286-46-2 Glimepiride EP Impurity A
Glimepiride USP-A
15 4-ethyl-3-methyl-5-oxo-N-[2-(4-sulfamoylphenyl)ethyl]-2H-pyrrole-1-carboxamide
C16H21N3O4S
M.Wt.: 351.42 		119018-29-0 Glimepiride EP Impurity B
Glimepiride USP-B
16 Methyl N-[4-[2-[(4-ethyl-3-methyl-5-oxo-2H-pyrrole-1-carbonyl)amino]ethyl]phenyl]sulfonylcarbamate
C18H23N3O6S
M.Wt.: 409.46 		119018-30-3 Glimepiride EP Impurity C
Glimepiride USP-C
17 4-ethyl-3-methyl-N-[2-[3-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide
C24H34N4O5S
M.Wt.: 490.62 		791104-62-6 Glimepiride EP Impurity D
Glimepiride USP-D;
18 (2R,3S)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol
C17H27NO4
M.Wt.: 309.40 		42200-33-9 Nadolol
19 cis-5-[(2RS)-2,3-Dihydroxypropoxy]-1,2,3,4-tetrahydronaphtalene-2,3-diol
C13H18O5
M.Wt.: 254.28 		- NA - Nadolol EP Impurity A
Nadolol alcohol (USP)
20 cis-5-[(2RS)-2-Hydroxy-3-methoxypropoxy]-1,2,3,4-tetrahydronaphtalene-2,3-diol
C14H20O5
M.Wt.: 268.31 		- NA - Nadolol EP Impurity B
Nadolol Methoxy analog (USP)
21 5,5' -[(2-Hydroxypropane-1,3-diyl)bis(oxy)]bis(cis-1,2,3,4-tetrahydronaphthalene-2,3-diol)
C23H28O7
M.Wt.: 416.46 		- NA - Nadolol EP Impurity C
Diaryl glycerol analog(USP)
22 5,5' [[(1,1-Dimethylethyl)imino]bis[(2-hydroxypropane-1,3-diyl)oxy]]bis(cis-1,2,3,4-tetrahydronaphthalene-2,3-diol)
C30H43NO8
M.Wt.: 545.66 		67247-26-1 Nadolol EP Impurity D Nadolol dimer (USP)
23 cis-5-[(2-RS)-3-[(1,1-Dimethylethyl)amino]-2-hydroxypropoxy]-8-iodo-1,2,3,4-tetrahydronaphtalene-2,3-diol
C17H26INO4
M.Wt: 435.3 		67247-33-0 Nadolol EP Impurity E
24 1-(tert-butylamino)-3-naphthalen-1-yloxypropan-2-ol
C17H23NO2
M.Wt: 273.4 		2116-22-5 Nadolol EP Impurity F; Naphthyl analoge(USP)
25 1-(tert-butylamino)-3-(5,6,7,8-tetrahydronaphthalen-1-yloxy)propan-2-ol
C17H27NO2
M.Wt: 277.4 		33841-03-1 Nadolol EP Impurity G; Dideoxy Nadolol (USP)
26 5-(2-bromoethyl)-2,3-dihydro-1-benzofuran
C10H11BrO
MWt: 227.10 		127264-14-6 Darifenacin related compound
27 2,2-diphenyl-2-[(3S)-pyrrolidin-3-yl]acetonitrile;hydrobromide
C18H19BrN2
M.Wt.: 343.26 		194602-27-2 Darifenacin related compound
28 (2R,3R)-2,3-dihydroxybutanedioic acid;2,2-diphenyl-2-[(3S)-pyrrolidin-3-yl]acetamide
C22H26N2O7
M.Wt.: 430.45 		134002-26-9 Darifenacin related compound
29 (S)-2-{1-[3-(2-Bromoethyl)-4-hydroxyphenethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide
C28H31BrN2O2
M.Wt.: 507.46 		- NA - Darifenacin related compound
30 (S)-2-[1-[2-(2,3-Dihydrobenzfuran-5-yl)ethyl]-3-pyrrolidinyl]-2,2-diphenyl-N-[2-(2,3-dihydrobenzfuran-5-yl)ethyl]acetamide hydrobromide
C38H41BrN2O3
M.Wt: 653.65 		- NA - Darifenacin related compound
31 (S)3-(2-Amino-2-oxo-1,1-diphenylethyl)-1,1-bis(2-(2,3-dihydrobenzofuran-5-yl)ethyl)pyrrolidin-1-ium bromide
C38H41BrN2O3
M.Wt.: 653.65 		- NA - Darifenacin related compound
32 Methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(E)-4-hydroxy-4-methyloct-1-enyl]-5-oxocyclopentyl]heptanoate
C22H38O5
M.Wt.: 382.53 		59122-46-2 Misoprostol
33 Methyl 7-[(1R,2S)-2-[(E)-4-hydroxy-4-methyloct-1-enyl]-5-oxocyclopent-3-en-1-yl]heptanoate
C22H36O4
M.Wt.: 364.52 		58682-86-3 Misoprostol EP Impurity C
34 Methyl 7-[2-[(E)-4-hydroxy-4-methyloct-1-enyl]-5-oxocyclopenten-1-yl]heptanoate
C22H36O4
M.Wt.: 364.52 		1331639-92-9 Misoprostol EP Impurity D
35 Methyl (1S*,2R*,3R*)-3-hydroxy-2-[(E)-4-hydroxy-4-methyl-1-octenyl]-5-oxocyclopentaneheptanoate
C22H38O5
M.Wt.: 382.53 		- NA - Misoprostol EP Impurity A
36 Methyl (1S*,2R*,3S*)-3-hydroxy-2-[(E)-4-hydroxy-4-methyl-1-octenyl]-5-oxocyclopentaneheptanoate
C22H38O5
M.Wt.: 382.53 		- NA - Misoprostol EP Impurity B
37 Methyl 7-[(1R,2R,3S)-3-hydroxy-2-[(E)-4-hydroxy-4-methyloct-1-enyl]-5-oxocyclopentyl]heptanoate
C22H38O5
M.Wt.: 382.53 		58717-36-5 Misoprostol EP Impurity E
38 Methyl 7-(3-hydroxy-5-oxocyclopenten-1-yl)heptanoate
C13H20O4
M.Wt: 240.30 		40098-26-8 Misoprostol EP impurity F
39 (Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(E)-(3R)-3-hydroxy-3-methyloct-1-enyl]cyclopentyl]-5-heptenoic acid.
C21H36O5
M.Wt.: 368.51 		- NA - 15-epi Carboprost
40 (E)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(E)-(3S)-3-hydroxy-3-methyloct-1-enyl]cyclopentyl]-5-heptenoic acid
C21H36O5
M.Wt.: 368.51 		- NA - trans-Carboprost
41 - - -
42 2-amino-2-(hydroxymethyl)propane-1,3-diol
C4H11NO3
M.Wt.: 121.14 		77-86-1 Tromethamine
43 (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]hept-5-enoic acid
C23H32O5
M.Wt.: 388.22 		38344-08-0 Bimatoprost S-Acid
44 (5Z)-7-((1R,2R,3R,5R)-3,5-dihydroxy-2-((S,E)-3-hydroxy-5-phenylpent-1-enyl)cyclopentyl)hept-5-enoic acid
C23H32O5
M.Wt.: 388.22 		- NA - Bimatoprost R-Acid
45 15-Keto Bimatoprost
C25H35NO4
Exact Mass: 413.26		 - NA - 15-Keto Bimatoprost
46 (5Z)-methyl 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxy-5-phenylpent-1-enyl)cyclopentyl)hept-5-enoate
C24H34O5
Exact Mass: 402.24 		- NA - Bimatoprost Acid
Methyl Ester
47 propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3R)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]hept-5-enoate
C26H38O5
M.Wt.: 430.58 		130273-87-9 Bimatoprost isopropyl ester
48 (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3R)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylhept-5-enamide
C25H37NO4
M.Wt.: 415.57 		1163135-92-9 15-epi Bimatoprost ((15R)-Bimatoprost)
49 ((E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylhept-5-enamide
C25H37NO4
M.Wt.: 415.57 		1163135-95-2 5.6 TRANS- BIMATOPROST IMPURITY
50 (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]hept-5-enoic acid
C23H29F3O6
M.Wt.: 458.19 		54276-17-4 Travoprost Acid


Suma Laboratories ® All rights reserved.